Natera (NTRA) Competitors $170.38 +3.03 (+1.81%) Closing price 04:00 PM EasternExtended Trading$166.34 -4.04 (-2.37%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NTRA vs. HIMS, GH, RDNT, BTSG, SHC, OPCH, WGS, PRVA, HTFL, and SGRYShould you be buying Natera stock or one of its competitors? The main competitors of Natera include Hims & Hers Health (HIMS), Guardant Health (GH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Option Care Health (OPCH), GeneDx (WGS), Privia Health Group (PRVA), Heartflow (HTFL), and Surgery Partners (SGRY). These companies are all part of the "healthcare" industry. Natera vs. Its Competitors Hims & Hers Health Guardant Health RadNet BrightSpring Health Services Sotera Health Option Care Health GeneDx Privia Health Group Heartflow Surgery Partners Natera (NASDAQ:NTRA) and Hims & Hers Health (NYSE:HIMS) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, risk, media sentiment, profitability, valuation, dividends and earnings. Which has more risk and volatility, NTRA or HIMS? Natera has a beta of 1.74, suggesting that its stock price is 74% more volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 2.25, suggesting that its stock price is 125% more volatile than the S&P 500. Which has stronger valuation & earnings, NTRA or HIMS? Hims & Hers Health has lower revenue, but higher earnings than Natera. Natera is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNatera$1.70B13.78-$190.43M-$1.91-89.20Hims & Hers Health$1.48B8.37$126.04M$0.8068.35 Do institutionals & insiders have more ownership in NTRA or HIMS? 99.9% of Natera shares are owned by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are owned by institutional investors. 5.6% of Natera shares are owned by insiders. Comparatively, 17.7% of Hims & Hers Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Is NTRA or HIMS more profitable? Hims & Hers Health has a net margin of 9.63% compared to Natera's net margin of -12.89%. Hims & Hers Health's return on equity of 26.26% beat Natera's return on equity.Company Net Margins Return on Equity Return on Assets Natera-12.89% -22.22% -15.03% Hims & Hers Health 9.63%26.26%13.06% Do analysts recommend NTRA or HIMS? Natera presently has a consensus target price of $192.88, indicating a potential upside of 13.21%. Hims & Hers Health has a consensus target price of $38.92, indicating a potential downside of 28.83%. Given Natera's stronger consensus rating and higher probable upside, analysts plainly believe Natera is more favorable than Hims & Hers Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Natera 1 Sell rating(s) 1 Hold rating(s) 17 Buy rating(s) 1 Strong Buy rating(s) 2.90Hims & Hers Health 3 Sell rating(s) 9 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.93 Does the media prefer NTRA or HIMS? In the previous week, Natera had 7 more articles in the media than Hims & Hers Health. MarketBeat recorded 22 mentions for Natera and 15 mentions for Hims & Hers Health. Hims & Hers Health's average media sentiment score of 0.68 beat Natera's score of 0.64 indicating that Hims & Hers Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Natera 11 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Hims & Hers Health 8 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive SummaryNatera and Hims & Hers Health tied by winning 8 of the 16 factors compared between the two stocks. Get Natera News Delivered to You Automatically Sign up to receive the latest news and ratings for NTRA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NTRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NTRA vs. The Competition Export to ExcelMetricNateraMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$22.97B$8.18B$6.15B$10.62BDividend YieldN/A2.80%5.64%4.69%P/E RatioN/A72.9685.6627.13Price / Sales13.7835.02527.36205.87Price / CashN/A23.0126.3031.10Price / Book18.836.8512.926.67Net Income-$190.43M$247.60M$3.30B$276.23M7 Day Performance4.47%1.53%4.80%3.31%1 Month Performance1.40%2.90%8.11%10.76%1 Year Performance31.22%11.33%75.85%33.58% Natera Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NTRANatera3.0262 of 5 stars$170.38+1.8%$192.88+13.2%+28.9%$22.97B$1.70B-89.204,434Positive NewsHIMSHims & Hers Health3.5191 of 5 stars$59.06+1.1%$38.92-34.1%+197.9%$13.35B$1.48B73.831,637Gap UpGHGuardant Health3.6868 of 5 stars$61.99+3.3%$65.25+5.3%+183.6%$7.73B$739.02M-18.502,021RDNTRadNet3.1 of 5 stars$74.70-1.6%$76.80+2.8%+13.1%$5.75B$1.83B-373.4811,021BTSGBrightSpring Health Services2.8145 of 5 stars$28.13+2.7%$27.10-3.7%+92.1%$4.98B$11.27B90.7435,000SHCSotera Health2.4348 of 5 stars$15.75-0.4%$16.00+1.6%+0.9%$4.47B$1.10B196.903,000OPCHOption Care Health4.8831 of 5 stars$27.54+0.9%$35.75+29.8%-5.7%$4.47B$5.00B22.038,088Positive NewsWGSGeneDx2.3226 of 5 stars$113.93-2.8%$104.13-8.6%+137.4%$3.27B$305.45M2,278.601,200PRVAPrivia Health Group3.8383 of 5 stars$24.42+1.9%$28.58+17.0%+37.0%$3.00B$1.90B222.021,140HTFLHeartflowN/A$34.50+4.4%$36.60+6.1%N/A$2.88BN/A0.00699SGRYSurgery Partners2.9981 of 5 stars$21.91+0.3%$32.88+50.0%-32.1%$2.81B$3.11B-15.3215,000Positive News Related Companies and Tools Related Companies HIMS Competitors GH Competitors RDNT Competitors BTSG Competitors SHC Competitors OPCH Competitors WGS Competitors PRVA Competitors HTFL Competitors SGRY Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NTRA) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredIs Nvidia about to Trigger Another 150X Opportunity?Nvidia gave investors a chance to make more than 150 times their money with its AI chips, known as graphics pr...InvestorPlace | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A Millionaire With SEVEN Clicks? $1,000 in just seven stocks in 2004 could have turned into a million-dolla...The Oxford Club | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Natera, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Natera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
